Common Fund Programs
Archived Initiatives
- Advancing Health Communication Science and Practice
- Big Data to Knowledge (BD2K)
- Bioinformatics and Computational Biology
- Bridging Interventional Development Gaps (BrIDGs)
- Building Blocks, Biological Pathways and Networks (BBPN)
- Clinical Research Policy Analysis and Coordination (CRpac)
- Clinical and Translational Science Awards (CTSAs)
- Epigenomics
- Genotype-Tissue Expression (GTEx)
- Glycoscience
- Gulf Oil Spill
- Healthcare Systems Research (HCS) Collaboratory
- Health Economics
- Human Microbiome Project (HMP)
- Interdisciplinary Research (IR)
- Knockout Mouse Phenotyping Program (KOMP2)
- Library of Integrated Network-based Cellular Signatures (LINCS)
- Metabolomics
- Molecular Libraries and Imaging
- Nanomedicine
- National Electronics Clinical Trials and Research (NECTAR)
- New Models of Data Stewardship (NMDS)
- NIH Medical Research Scholars Program (MRSP)
- Patient-Reported Outcomes Measurement Information System (PROMIS)
- Protein Capture Reagents Program (PCRP)
- Regenerative Medicine Program (RMP)
- Regulatory Science
- Science of Behavior Change (SOBC)
- Single Cell Analysis Program (SCAP)
- Strengthening the Biomedical Research Workforce
- Structural Biology
- Undiagnosed Diseases Network (UDN)
Common Fund programs capitalize on emerging opportunities to catalyze the rate of progress across multiple biomedical fields. Programs are expected to transform the way a broad spectrum of health research is conducted. Initiatives that comprise Common Fund programs are intended to be catalytic in nature by providing limited term investments in strategic areas to stimulate further research through IC-funded mechanisms.
For these reasons, programs are intended to transition out of the Common Fund in 10 years or less as they mature.
For more information on specific former Common Fund programs, please refer to the programs listed above.
Through the American Recovery and Reinvestment Act (ARRA), the Common Fund received approximately $137M to be spent in fiscal years 2009 and 2010. As a result several awards were funded across a range of biomedical research areas.
